Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma

Figure 2

Construction and validation of the ICG-related prognostic risk model in KIRC. (a) The univariate Cox analysis. (b) The multivariate Cox analysis. (c) Distribution of KIRC-ICGscore. (d) Distribution of survival status. (e) The Kaplan-Meier analysis on the two KIRC-ICG subgroups. (f) The ROC curve of the KIRC-ICG model at 1, 3, and 5 years. ICGs: immune checkpoint genes.

(a)

(b)

(c)

(d)

(e)

(f)